Here are three updates:
1. Jeffries presently has a $48 price target on Orthofix shares.
2. In July, Sidoti gave the shares a “buy rating.”
3. Sidoti has a $43 price target on the company’s shares.
More device news:
Titan Spine launches nanoLOCK surface technology nationwide: 5 highlights
Dr. Steven C. Schallhorn tapped as CMO of global ophthalmic devices for Carl Zeiss Meditec: 3 thoughts
Medtronic, Depuy Synthes lead cervical total disc replacement device market: 6 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
